Medlock Holmes is called to investigate a troubling mystery among the youngest citizens of the city.
There is no dealer on the street corner.
No hidden laboratory.
No expensive supply chain.
Instead, the clues are ordinary household objects: glue, paint thinner, spray cans, lighter fluid, petrol, correction fluid, cleaning products, and aerosol dusters.
At first, the city dismisses the danger.
These are not “real drugs”, people say.
They are products.
They are everywhere.
But Holmes knows that availability can be the most dangerous disguise of all.
Inhalants are volatile substances that rapidly vaporise and are inhaled for psychoactive effects. Their intoxication arrives quickly because the lungs deliver these chemicals directly into the bloodstream and then to the brain. Within minutes, a young person may experience euphoria, disinhibition, dizziness, slurred speech, unsteady gait, hallucinations, confusion, or collapse.
Holmes notices that inhalant use is especially common in early adolescence. The appeal is obvious: the substances are cheap, legal, easy to conceal, and difficult to detect on routine toxicology screens. Yet the danger is profound. A single episode can cause suffocation, aspiration, burns, trauma, seizures, coma, respiratory depression, or sudden cardiac death.
As Holmes follows the trail deeper, he discovers that chronic inhalant use is not merely a behavioural problem. It is a toxic assault on the body. The brain, rich in lipids and myelinated tissue, is particularly vulnerable. Long-term use can damage white matter, impair memory and executive functioning, cause cerebellar problems, produce neuropathy, and contribute to major or mild neurocognitive disorder.
The investigation also reveals a familiar pattern of psychiatric complexity. Inhalant use is often associated with conduct disorder, trauma, neglect, suicidality, mood and anxiety disorders, antisocial traits, and polysubstance use. For some adolescents, experimentation stops quickly. For others, inhalants become an early warning signal of a much broader developmental pathway involving impulsivity, risk-taking, marginalisation, and future substance dependence.
Treatment is difficult because the evidence base is limited. There is no simple medication that reverses inhalant use disorder. Care requires careful medical assessment, management of intoxication, attention to neurological and cognitive injury, family work, trauma-informed care, school and social support, relapse prevention, and treatment of comorbid psychiatric and substance use disorders.
By the end of the case, Holmes realises that inhalants are dangerous precisely because they are ordinary.
The threat does not always arrive wearing the face of crime.
Sometimes it sits quietly on a shelf, waiting to be misunderstood.
Key Takeaways
Inhalants are volatile substances inhaled for psychoactive effects.
Common sources include glues, paints, thinners, fuels, aerosols, cleaning products, correction fluids, and dusters.
Use is most common in younger adolescents and tends to decline with age.
Inhalant intoxication can cause euphoria, disinhibition, dizziness, slurred speech, ataxia, hallucinations, confusion, stupor, coma, or death.
A single episode may be fatal through arrhythmia, suffocation, aspiration, respiratory depression, burns, trauma, or seizures.
Routine drug screens often miss inhalant use.
Clues include chemical odour, stained clothing, solvent-soaked rags, bags, aerosol cans, or perioral/perinasal rash.
Chronic use can cause neurological injury, white matter damage, cognitive impairment, neuropathy, cerebellar signs, and neurocognitive disorder.
Inhalant use is strongly associated with conduct disorder, trauma, suicidality, polysubstance use, mood disorders, anxiety disorders, and social adversity.
Inhalant-induced psychiatric disorders may include delirium, psychosis, depressive disorder, anxiety disorder, and neurocognitive disorder.
Management of intoxication is mainly supportive, with careful monitoring of airway, breathing, circulation, consciousness, and cardiac risk.
Agitation should be managed cautiously because physical excitement may increase arrhythmia risk.
Benzodiazepines may worsen respiratory depression during acute intoxication and require caution.
Treatment of inhalant use disorder usually requires broad biopsychosocial care rather than substance-specific medication.
Prevention, early recognition, family involvement, and community support are especially important.
